Merck & Co., Inc. (MRK) Shares Outstanding: 2.50
Is Merck & Co., Inc.’s shares outstanding high or low?
Merck & Co., Inc.'s shares outstanding of 2.50 is in line with its 5-year average of 2.54, near the low end of its 5-year range (2.50–2.61).
The shares outstanding for Merck & Co., Inc. (MRK) is 2.50. It is below its 12-month average by 0.60% (2.52).
MRK Shares Outstanding Chart
MRK Average Shares Outstanding Chart
MRK Current vs Average Shares Outstanding Chart
MRK Shares Outstanding Metrics
SHARES OUTSTANDING
2.50
SHARES OUTSTANDING AVG TTM
2.52
SHARES OUTSTANDING AVG 3Y
2.54
SHARES OUTSTANDING AVG 5Y
2.54
SHARES OUTSTANDING AVG 10Y
2.60
SHARES OUTSTANDING AVG 15Y
2.72
SHARES OUTSTANDING AVG 20Y
2.59
CURRENT VS TTM AVG
-0.60%
CURRENT VS 3Y AVG
-1.62%
CURRENT VS 5Y AVG
-1.45%
CURRENT VS 10Y AVG
-3.83%
CURRENT VS 15Y AVG
-8.07%
CURRENT VS 20Y AVG
-3.30%
Share Structure
Shares Outstanding
2.50B
Float Shares
N/A
Stock Price
$119.60
Market Cap
$295.4B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 2.50B | -1.18% |
| 2024 | 2.53B | -2.88% |
| 2023 | 2.61B | +2.97% |
| 2022 | 2.53B | +0.08% |
| 2021 | 2.53B | +0.00% |
| 2020 | 2.53B | -1.36% |
| 2019 | 2.56B | -1.06% |
| 2018 | 2.59B | -3.86% |
| 2017 | 2.70B | -1.90% |
| 2016 | 2.75B | -1.16% |
| 2015 | 2.78B | -2.01% |
| 2014 | 2.84B | -3.05% |
| 2013 | 2.93B | -3.27% |
| 2012 | 3.03B | -0.47% |
| 2011 | 3.04B | -1.75% |
| 2010 | 3.10B | +46.79% |
| 2009 | 2.11B | -1.29% |
| 2008 | 2.14B | -1.59% |
| 2007 | 2.17B | -0.33% |
| 2006 | 2.18B | -0.88% |
| 2005 | 2.20B | -0.99% |
| 2004 | 2.22B | -0.79% |
| 2003 | 2.24B | -0.92% |
| 2002 | 2.26B | -1.35% |
| 2001 | 2.29B | -0.81% |
| 2000 | 2.31B | -1.79% |
| 1999 | 2.35B | -1.08% |
| 1998 | 2.37B | -1.18% |
| 1997 | 2.40B | -0.93% |
| 1996 | 2.43B | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Merck & Co., Inc. Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Merck & Co., Inc. Shares Outstanding FAQ
- What is the shares outstanding for Merck & Co., Inc. (MRK)?
- The shares outstanding for MRK stock is 2.50.
- Is Merck & Co., Inc.'s shares outstanding high or low?
- Merck & Co., Inc.'s shares outstanding of 2.50 is in line with its 5-year average of 2.54, near the low end of its 5-year range (2.50–2.61).
- What is the TTM average shares outstanding for Merck & Co., Inc. (MRK)?
- The TTM average shares outstanding for MRK stock is 2.52.
- What is the 3Y average shares outstanding for Merck & Co., Inc. (MRK)?
- The 3Y average shares outstanding for MRK stock is 2.54.
- What is the 5Y average shares outstanding for Merck & Co., Inc. (MRK)?
- The 5Y average shares outstanding for MRK stock is 2.54.
- What is the 10Y average shares outstanding for Merck & Co., Inc. (MRK)?
- The 10Y average shares outstanding for MRK stock is 2.60.
- What is the 15Y average shares outstanding for Merck & Co., Inc. (MRK)?
- The 15Y average shares outstanding for MRK stock is 2.72.
- What is the 20Y average shares outstanding for Merck & Co., Inc. (MRK)?
- The 20Y average shares outstanding for MRK stock is 2.59.
Merck & Co., Inc. Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-12-31 | 2.50 |
| 2024-12-31 | 2.53 |
| 2023-12-31 | 2.61 |
| 2022-12-31 | 2.53 |
| 2021-12-31 | 2.53 |
| 2020-12-31 | 2.53 |
| 2019-12-31 | 2.56 |
| 2018-12-31 | 2.59 |
| 2017-12-31 | 2.70 |
| 2016-12-31 | 2.75 |
| 2015-12-31 | 2.78 |
| 2014-12-31 | 2.84 |
| 2013-12-31 | 2.93 |
| 2012-12-31 | 3.03 |
| 2011-12-31 | 3.04 |
| 2010-12-31 | 3.10 |
| 2009-12-31 | 2.11 |
| 2008-12-31 | 2.14 |
| 2007-12-31 | 2.17 |
| 2006-12-31 | 2.18 |
| 2005-12-31 | 2.20 |
| 2004-12-31 | 2.22 |
| 2003-12-31 | 2.24 |
| 2002-12-31 | 2.26 |
| 2001-12-31 | 2.29 |
| 2000-12-31 | 2.31 |
| 1999-12-31 | 2.35 |
| 1998-12-31 | 2.37 |
| 1997-12-31 | 2.40 |
| 1996-12-31 | 2.43 |
Related Metrics
About Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Robert Davis